{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:53:42Z","timestamp":1789055622161,"version":"build-2803163510"},"reference-count":14,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.3960\/jslrt.24028","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T22:13:17Z","timestamp":1719871997000},"page":"216-222","source":"Crossref","is-referenced-by-count":2,"title":["Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan"],"prefix":"10.3960","volume":"64","author":[{"given":"Motoko","family":"Yamaguchi","sequence":"first","affiliation":[{"name":"Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Takizawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishitsuka","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yokohama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Nato","sequence":"additional","affiliation":[{"name":"Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mitobe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodai","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Miyazawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Izutsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Shimane University School of Medicine, Izumo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University, Isehara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36: 1720-1748.","DOI":"10.1038\/s41375-022-01620-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Pawson R, Dyer MJ, Barge R <i>et al.<\/i> Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. J Clin Oncol. 1997; 15: 2667-2672.","DOI":"10.1200\/JCO.1997.15.7.2667"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Dearden CE, Matutes E, Cazin B <i>et al.<\/i> High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood. 2001; 98: 1721-1726.","DOI":"10.1182\/blood.V98.6.1721"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Keating MJ, Cazin B, Coutr\u00e9 S <i>et al.<\/i> Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed. J Clin Oncol. 2002; 20: 205-213.","DOI":"10.1200\/JCO.20.1.205"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Jain P, Aoki E, Keating M <i>et al.<\/i> Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL). Ann Oncol. 2017; 28: 1554-1559.","DOI":"10.1093\/annonc\/mdx163"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Dearden CE, Khot A, Else M <i>et al.<\/i> Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route. Blood. 2011; 118: 5799-5802.","DOI":"10.1182\/blood-2011-08-372854"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Staber PB, Herling M, Bellido M <i>et al.<\/i> Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia. Blood. 2019; 134: 1132-1143.","DOI":"10.1182\/blood.2019000402"},{"key":"8","unstructured":"8 NCCN Guidelines T-Cell Lymphomas Version I. 2023. Vol. 2023."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ichikawa S, Fukuhara N, Saito K <i>et al.<\/i> Epstein-Barr virus-positive diffuse large B-cell lymphoma after sustained remission of T-cell prolymphocytic leukemia with alemtuzumab. Leuk Lymphoma. 2020; 61: 1504-1507.","DOI":"10.1080\/10428194.2020.1713322"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Mori J, Oshima K, Kimura S, Ikezoe T. Treatment of T-Cell Prolymphocytic Leukemia with Central Nervous System Involvement Using Intrathecal Alemtuzumab Administration. Case Rep Hematol. 2020; 2020: 8822172.","DOI":"10.1155\/2020\/8822172"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Okada N, Yamamoto R, Maruoka H <i>et al.<\/i> Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report. Case Rep Oncol. 2023; 16: 604-612.","DOI":"10.1159\/000531471"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Yamasaki S, Nitta H, Kondo E <i>et al.<\/i> Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation. Ann Hematol. 2019; 98: 2213-2220.","DOI":"10.1007\/s00277-019-03759-y"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Herbaux C, Kornauth C, Poulain S <i>et al.<\/i> BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia. Blood. 2021; 137: 3495-3506.","DOI":"10.1182\/blood.2020007303"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Braun T, von Jan J, Wahnschaffe L, Herling M. Advances and Perspectives in the Treatment of T-PLL. Curr Hematol Malig Rep. 2020; 15: 113-124.","DOI":"10.1007\/s11899-020-00566-5"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/3\/64_24028\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T05:06:20Z","timestamp":1727499980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/3\/64_24028\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.24028","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"24028"}}